Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest announcement is out from Little Green Pharma Ltd. ( (AU:LGP) ).
Little Green Pharma Ltd. is committed to redefining healthcare through its focus on alternative medicines, aiming to become a market leader in Australia and Europe. The company’s vision highlights its dedication to improving the quality of life for millions, suggesting a significant impact on its market positioning and potential benefits for stakeholders.
The most recent analyst rating on (AU:LGP) stock is a Buy with a A$0.21 price target. To see the full list of analyst forecasts on Little Green Pharma Ltd. stock, see the AU:LGP Stock Forecast page.
More about Little Green Pharma Ltd.
Little Green Pharma Ltd. operates in the healthcare industry, focusing on alternative medicines. The company aims to lead the market in Australia and Europe, enhancing the quality of life for millions.
Average Trading Volume: 101,264
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$30.4M
For a thorough assessment of LGP stock, go to TipRanks’ Stock Analysis page.